Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Study of Oral Metronidazole vs. Oral Metronidazole and Rifampin for Treatment of Clostridium Difficile-associated Diarrhea (CDAD)

NCT00182429 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT00182429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00182429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Study of Oral Metronidazole vs. Oral Metronidazole and Rifampin for Treatment of Clostridium Difficile-associated Diarrhea (CDAD)
Lead sponsor
McMaster University
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2004
Completion date
December 31, 2005
Enrollment
100
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic-associated diarrhea, clostridium enterocolitis, pseudomembranous colitis, pseudomembranous enteritis, pseudomembranous enterocolitis